Cell Reports
Volume 33, Issue 9, 1 December 2020, 108454
Journal home page for Cell Reports

Article
The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein

https://doi.org/10.1016/j.celrep.2020.108454Get rights and content
Under a Creative Commons license
open access

Highlights

  • Dendritic cells display peptides spanning the entire SARS-CoV-2 spike protein

  • HLA-II peptides from 11 regions are presented by a majority of the analyzed donors

  • One region with promiscuous HLA-II presentation is conserved with SARS-CoV

  • The correlation of presented to predicted peptides is low

Summary

Precise elucidation of the antigen sequences for T cell immunosurveillance greatly enhances our ability to understand and modulate humoral responses to viral infection or active immunization. Mass spectrometry is used to identify 526 unique sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen-presenting cells from a panel of healthy donors selected to represent a majority of allele usage from this highly polymorphic molecule. The identified sequences span the entire spike protein, and several sequences are isolated from a majority of the sampled donors, indicating promiscuous binding. Importantly, many peptides derived from the receptor binding domain used for cell entry are identified. This work represents a precise and comprehensive immunopeptidomic investigation with the SARS-CoV-2 spike glycoprotein and allows detailed analysis of features that may aid vaccine development to end the current coronavirus disease 2019 (COVID-19) pandemic.

Keywords

immunopeptidomics
HLA-II
mass spectrometry
MAPPs
spike glycoprotein
coronavirus
immune response
dendritic cell
peptide
COVID-19

Cited by (0)

2

Lead Contact